期刊文献+

儿童慢性肉芽肿病1例临床特征及基因突变分析 被引量:2

The analysis of clinical manifestations and genetic mutations in childhood chronic granulomatous disease
下载PDF
导出
摘要 目的探讨慢性肉芽肿病的致病机制以及诊断。方法回顾性分析1例慢性肉芽肿病患儿的临床特征及实验室检查;提取患儿及父母外周血基因组DNA,用Agilent Sure Select方法外显子捕获,Illumina测序平台进行高通量测序。结果患儿有反复感染史,伴肝脏肿大和肝功能异常,抗感染及对症治疗效果不佳。二代测序显示患儿CYBA基因存在c.7C?>?T(p.Gln3*)纯合突变,其母为该位点杂合,父亲可能存在大片段杂合缺失,其他候选基因测序分析未发现明显异常。结论确诊患儿为慢性肉芽肿病,CYBA基因突变是其致病原因。 Objective To explore the pathogenesis and diagnosis of chronic granulomatous disease. Methods Clinical features and laboratory examination results of a child with chronic granulomatous disease were retrospectively analyzed. Genome DNA was extracted from peripheral blood of the child and his parents. The high-throughput sequencing was performed by Illumina sequencing platform, using the Agilent SureSelect exome capture method. Results The child had recurrent infections along with liver enlargement and dysfunction. The anti-infection and symptomatic treatment were unsatisfactory. Gene sequencing analysis revealed a homozygous point mutation (c.7C?>?T, p.Gln3*) in CYBA gene. His mother had the same heterozygous mutation in this locus, and his father had a large fragment heterozygous deletions. No other candidate gene mutations were identiifed. Conclusions The diagnosis of chronic granulomatous disease is conifrmed in this child. It is caused by CYBA gene mutation.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2016年第3期204-207,共4页 Journal of Clinical Pediatrics
关键词 慢性肉芽肿病 CYBA基因突变 肝功能损害 儿童 chronic granulomatous disease CYBA mutations hepatic abnormalities child
  • 相关文献

参考文献16

  • 1Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronicgranulomatous disease.Report on a national registry of 368patients [J]. Medicine (Batimore), 2000, 79(3): 155-169.
  • 2Roos D, de Boer M, Koker MY, et al. Chronic granulomatousdisease caused by mutations other than the common GTdeletion in NCF1, the gene encoding the p47 phox componentof the phagocyte NADPH oxidase [J]. Hum Mutat, 2006,27(12): 1218-1229.
  • 3McCabe RP. Gastrointestinal manifestations of Non-AIDSimmunodeficiency [J]. Curr Treat Options Gastroenterol,2002, 5(1): 17-25.
  • 4Barton LL, Moussa SL, Villar RG, et al. Gastrointestinalcomplications of chronic granulomatous disease: case reportand literature review [J]. Clin Pediatr (Phila) , 1998, 37(4):231-236.
  • 5Zimmerman HJ. Drug-induced liver disease [J]. Clin LiverDis, 2000, 4(1): 73-96.
  • 6Maldonado O, Demasi R, Maldonado Y, et al. Extremelyhigh levels of alkaline phosphatase in hospitalized patients[J]. Clin Gastroenterol, 1998, 27(4): 342-345.
  • 7Essop AR, Posen JA, Hodkinson JH, et al. Tuberculosishepatitis: a clinical review of 96 cases [J]. Med, 1984,53(212): 465-477.
  • 8Alvarez-Larran A, Toll T, Rives S, et al. Assessment ofneutrophil activation in whole blood by flow cytometry [J].Clin Lab Haematol, 2005, 27(1): 41-46.
  • 9Segal BH, Romani L, Puccetti P. Chronic granulomatousdisease [J].Cell Mol Life Sci, 2009, 66(4): 553-558.
  • 10王美红,张建华.慢性肉芽肿病及其基因突变[J].国际儿科学杂志,2006,33(6):423-425. 被引量:4

二级参考文献16

  • 1Jirapongsananuruk O,Malech HL,Kuhns DB,et al.Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease,based on the dihydrorhodamine 123 assay[J].J Allergy Clin Immunol,2003,111(2):374-379.
  • 2Jirapongsananuruk O,Niemela JE,Malech HL,et al.CYBB mutation analysis in X-linked chronic granulomatous disease[J].Clin Immunol,2002,104 (1):73-76.
  • 3Noack D,Heyworth PG,Kyono W,et al.A second case of somatic triple mosaicism in the CYBB gene causing chronic granulomatous disease[J].Hum Genet,2001,109(2):234-238.
  • 4Ishibashi F,Mizukami T,Kanegasaki S,et al.Improved superoxide-generating ability by interferon gamma due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene[J].Blood,2001,98(2):436-441.
  • 5de Boer M,Hartl D,Wintergerst U,et al.A donor splice site mutation in intron 1 of CYBA,leading to chronic granulomatous disease[J].Blood Cells Mol Dis,2005,35(3):365-369.
  • 6Segal BH,Leto TL,Gallin JI,et al.Genetic,biochemical,and clinical features of chronic granulomatous disease[J].Medicine(Baltimore),2000,79(3):170-200.
  • 7Lin SJ,Huang YF,Chen JY,et al.Molecular quality control machinery contributes to the leukocyte NADPH oxidase deficiency in chronic granulomatous disease[J].Biochim Biophys Acta,2002,1586(3):275-286.
  • 8Jurkowska M,Bernatowska E,Bal J.Genetic and biochemical background of chronic granulomatous disease[J].Arch Immunol Ther Exp(Warsz),2004,52(2):113-120.
  • 9Bleesing JJ,Souto-Cameiro MM,Savage WJ,et al.Patients with chronic granulomatous disease have a reduced peripheral blood memory c Cell compartment[J].J Immunol,2006,176(11):7096-7103.
  • 10Gu Y,Jia B,Yang FC,et al.Biochemical and biological characterization of a human Rac2 GTPase mutant associated with phagocytic immunodeficiency[J].J Biol Chem,2001,276(19):15929-15938.

共引文献3

同被引文献10

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部